Hokkaido University · Faculty of Medicine / Graduate School of Medicine / Medical Research Institute

Research keywordsneuroendocrine tumors・pheochromocytoma paraganglioma・FDG PET/CT・MIBG scintigraphy・targeted sequencing・adrenocortical carcinoma・peptide receptor radionuclide therapy・NETest biomarker

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Multidisciplinary surgical management with chemotherapy and transcatheter arterial embolization for a giant hypervascular pancreatic neuroendocrine tumor.2025 · Clinical journal of gastroenterology, 2025年09月30日,
• Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors.2025 · Annals of nuclear medicine, 2025年04月05日,
• Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.2025 · JCO precision oncology, 9, e2400437, 2025年01月,
• Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [131I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study2025 · Pharmaceuticals, 18, 2, 165, 165, MDPI AG, 2025年01月26日

• 低酸素腫瘍に対する新たな治療戦略の構築
• 半導体PETと深層学習を利用したFDG PETからの腫瘍血流・代謝の同時定量

• Official profile